The rationale for application of NSAIDs in Alzheimer's therapy

被引：0
|
作者：
Weggen, Sascha [1 ]
机构：
[1] Univ Mainz, Emmy Noether Res Grp, Inst Physiol Chem & Pathobiochem, D-55128 Mainz, Germany
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：1272 / 1272
页数：1
相关论文
共 50 条
  • [11] NSAIDs may not prevent Alzheimer's disease
    不详
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (06) : 785 - 785
  • [12] Can NSAIDs contribute to Alzheimer's disease?
    Secko, D
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (13) : 1677 - 1677
  • [13] NSAIDs do not slow Alzheimer's progression
    Frankish, H
    [J]. LANCET, 2003, 361 (9373): : 1964 - 1964
  • [14] NSAIDs can lower risk of Alzheimer's
    Gottlieb, S
    [J]. BRITISH MEDICAL JOURNAL, 2001, 323 (7324): : 1269 - 1269
  • [15] How NSAIDs may fight Alzheimer's
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2001, 79 (46) : 23 - 23
  • [16] Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
    Bouwman, Femke H.
    Frisoni, Giovanni B.
    Johnson, Sterling C.
    Chen, Xiaochun
    Engelborghs, Sebastiaan
    Ikeuchi, Takeshi
    Paquet, Claire
    Ritchie, Craig
    Bozeat, Sasha
    Quevenco, Frances-Catherine
    Teunissen, Charlotte
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
  • [17] NSAIDS and Alzheimer's disease: it's only Rock and Rho
    Burton, A
    [J]. LANCET NEUROLOGY, 2004, 3 (01): : 6 - 6
  • [18] A β-42 peptide lowering NSAIDs and Alzheimer's disease
    Breteler, MMB
    Veld, BIH
    Hofman, A
    Stricker, BHC
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S286 - +
  • [19] How NSAIDs might prevent Alzheimer's disease
    Bradbury, J
    [J]. LANCET NEUROLOGY, 2004, 3 (11): : 638 - 638
  • [20] NSAIDs reduce Alzheimer's independently of COX activity
    Cheryl Smythe
    [J]. Arthritis Research & Therapy, 4 (1)
12345